Top 300 - Genitourinary

5.0(1)
studied byStudied by 2 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/53

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

54 Terms

1
New cards

Brand names of Oxybutynin?

Ditropan, Gelnique Top Gel, Oxytrol TD patch

2
New cards

Class of oxybutynin?

Antimuscarinic

3
New cards

Indication of oxybutynin?

Overactive or neurogenic bladder (primary hyperhidrosis- off-label)

4
New cards

MOA of oxybutynin?

Competitive muscarinic receptor antagonist; antispasmodic

5
New cards

Major contraindications for oxybutynin?

hypersensitivity to oxybutynin, gastric retention, glaucoma, urinary retention.

6
New cards

BBW of oxybutynin?

NONE

7
New cards

ADRs Common for Oxybutynin?

constipation, xerostomia, blurred vision.

8
New cards

ADRs Rare for oxybutynin?

Prolonged QTc interval, seizures, tachycardia.

9
New cards

Counseling for oxybutynin?

Anticholinergic effects, including constipation, urinary retention, blurred vision, dyspepsia, or xerostomia. Impaired cognitive function - elderly

10
New cards

Brand name of mirabegron?

Myrbetriq

11
New cards

Class of mirabegron?

beta-3 adrenergic receptor agonist

12
New cards

Indication of mirabegron?

Overactive bladder, neurogenic detrusor overactivity (children/adolescents).

13
New cards

MOA of mirabegron?

activates beta-3 adrenergic receptors resulting in relaxation of the detrusor smooth muscle and increasing bladder capacity.

14
New cards

Major contraindications of mirabegron?

hypersensitivity

15
New cards

BBW of mirabegron?

NONE

16
New cards

ADRs common of mirabegron?

HTN (vibregron does not have this same concern!!!!)

17
New cards

ADRs Rare of mirabegron?

atrial fibrillation, angioedema, hallucinations, increased liver function enzymes.

18
New cards

Counseling for mirabegron?

Monitor BP and HR and contact HCP for fast heartbeat or elevations in BP, bladder irritation or difficulty with urination

19
New cards

Brand name of finasteride?

Proscar, Propecia

20
New cards

Class of finasteride?

5-alpha-reductase inhibitor (5-ARI)

21
New cards

Indication of finasteride?

Benign prostatic hyperplasia (BPH), male pattern alopecia (hirsutism - off-label)

22
New cards

MOA of finasteride?

inhibits the conversion of testosterone to 5a-dihydrotestosterone (DHT) by 5a-reductase, isoform 2. Results in decreases in static component of BPH (hyperplasia)

23
New cards

Major contraindications of finasteride?

hypersensitivity, pregnancy (including women of child-bearing age coming in contact), use in children

24
New cards

BBW of finasteride?

NONE

25
New cards

ADRs common for finasteride?

impotence, reduced libido, gynecomastia, dizziness.

26
New cards

ADRs rare of finasteride?

heart failure, angioedema, allergic skin reactions, male breast cancer, prostate cancer (high grade)

27
New cards

Counseling for finasteride?

Delayed effects (3 months alopecia, 3-6 month BPH), absorption through skin or from semen can prevent development of genitalia in an unborn male, avoid blood donation as recipient may be pregnant

28
New cards

Brand name of Tamsulosin?

Flomax

29
New cards

Class of tamsulosin?

alpha-blocker

30
New cards

Indication of tamsulosin?

Benign prostatic hyperplasia (off-label uses: neurogenic bladder, bladder outlet obstruction (BOO) symptoms such as ureteral stones and expulsion.)

31
New cards

MOA of tamsulosin?

selectively block postsynaptic a-1-adrenergic receptors, specifically a-1A (prostate) and a-1D (bladder neck) reducing dynamic muscle tone

32
New cards

Major contraindications of tamsulosin?

hypersensitivity

33
New cards

BBW of tamsulosin?

NONE

34
New cards

ADRs common for tamsulosin?

dizziness, headache, abnormal ejaculation, rhinitis

35
New cards

ADRs Rare for tamsulosin?

retinal detachment, priapism

36
New cards

Counseling for tamsulosin?

orthostatic hypotension with 1st generation drugs. 2nd generation less likely to cause hypotension due to specificity to prostate receptors

37
New cards

Brand name of tadalafil?

Cialis, Adcirca

38
New cards

Class of tadalafil?

phosphodiesterase type 5 (PDE5) inibitor

39
New cards

Indication for tadalafil?

erectile dysfunction (ED); BPH; Pulmonary HTN

40
New cards

MOA of tadalafil?

inhibition of phosphodiesterase type 5 (PDE5) increases cyclic guanosine monophosphate (c-GMP); results in vascular smooth muscle relaxation resulting in increased blood flow into the corpus cavernosum (ED) and vasodilation in the pulmonary bed (pulmonary HTN)

41
New cards

Major contraindication of tadalafil?

hypersensitivity to PDE5 inhibitors, concurrent nitrates, concurrent HIV protease inhibitors when used for treating pulmonary HTN, concurrent guanylate cyclase stimulators.

42
New cards

BBW of tadalafil?

NONE

43
New cards

ADRs common for tadalafil?

flushing, nausea, headache, visual disturbances, lack of blue/green color discrimination.

44
New cards

ADRs rare for tadalafil?

AMI, seizures, strokes, sudden hearing loss, priapism.

45
New cards

Counseling for tadalafil?

take 30 min-4hour prior to anticipated sexual activity, but not more frequently than q24h. Sexual stimulation is required to initiate response; the inhibition of PDE5 has no effect in the absence of sexual stimulation.

46
New cards

Brand name of phenazopyridine?

Pyridium (OTC: Azo, Uristat)

47
New cards

Class of phenazopyridine?

urinary tract analgesic

48
New cards

Indication of phenazopyridine?

Dysuria (off-label uses: diagnostic aid, for ureteral or bladder visualization)

49
New cards

MOA of phenazopyridine?

topical analgesic effect on the mucosa of the urinary tract; relieves pain, burning, urgency, and frequency. The precise MOA is unknown.

50
New cards

Major contraindications for phenazopyridine?

hypersensitivity, renal failure

51
New cards

BBW for phenazopyridine?

NONE

52
New cards

ADRs common for phenazopyridine?

GI upset

53
New cards

ADRs Rare for phenazopyridine?

anaphylaxis, methemoglobinemia, hemolytic anemia, hepatotoxicity, nephrotoxicity.

54
New cards

Counseling for phenazopyridine?

drug may discolor urine and sclera to red or orange, causing staining of undergarments and contact lenses. Take drug with food to minimize gastric irritation. Limit to 2 days of therapy.